Fiducial markers play a vital role in target localization and tracking. With the Beacon™ fine needle fiducial (FNF) pre-loaded needle, you can confidently and independently deploy markers to help optimize patient management by potentially expediting patient treatment and reducing hospital stay duration.1-2

The needle is designed with a passive safety shielding feature to aid in the prevention of needle stick injury.

Fiducial brochure

View Brochure
Order Information
Order Code Product Description Unit of Measure Quantity
DSF-19-01 Beacon™ EUS Delivery System with FNF Pre-loaded 19-Gauge Needle Each 1
DSF-22-01 Beacon™ EUS Delivery System with FNF Pre-loaded 22-Gauge Needle Each 1
F-19-05 Beacon™ EUS FNF Pre-loaded 19-Gauge Needle  Box 5
F-22-05 Beacon™ EUS FNF Pre-loaded 22-Gauge Needle  Box 5

Order Information

Two fiducial markers. One endoscopic ultrasound (EUS) system.

  • Pre-loaded with two solid gold fiducial markers available in two sizes — 22 Ga (0.43 mm x 5 mm) and 19 Ga (0.75 mm x 5 mm)
  • The Beacon™ EUS delivery system enables interchangeability between the SharkCore™ FNB needles and Beacon™ FNF needles, allowing you to acquire tissue samples and place the markers in the same procedural setting.1
  • Caution: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner. Rx only.

  • Risk Information: Beacon™ fine needle pre-loaded fiducial system: Procedural risks associated with gastrointestinal endoscopy include, but are not limited to: perforation, hemorrhage, aspiration, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest, infection/fever, bacteremia, allergic reaction to medication, damage to blood vessels, nerve damage, tumor seeding of the needle tract, and acute pancreatitis. Those associated with EUS fiducial placement include, but are not limited to: improper fiducial placement, fiducial migration, infection/fever, allergic reaction, local inflammatory foreign body response, minor bleeds, pain, pancreatitis, and needle fracture requiring intervention for removal. Please refer to the product user manual for detailed information.

  • 1. Choi, J. H., Seo, D. W., Do Hyun Park, S. K. L., & Kim, M. H. (2014). Fiducial placement for stereotactic body radiation therapy under only endoscopic ultrasonography guidance in pancreatic and hepatic malignancy: practical feasibility and safety. Gut and Liver. 8(1): 88–93.

  • 2. Kothari S, Kothari T, et al. 234, Endoscopic Ultrasound (EUS)-Guided Fiducial Placement for Stereotactic Body Radiotherapy (SBRT): First Global Experience with a New 22-Gauge “Pre-loaded” EUS Fiducial Needle. The American Journal of Gastroenterology. 2015;110, (Issue - p S102).